The effects of milrinone and dobutamine upon BNP levels in patients with NYHA-class IV decompensated heart failure

被引：0
|
作者：
Pontes-Arruda, A [1 ]
机构：
[1] Fernandes Tavora Hosp, Dept Intens Care, Fortaleza, Ceara, Brazil
来源：
CRITICAL CARE MEDICINE | 2005年 / 33卷 / 12期
关键词：
D O I：
10.1097/00003246-200512002-00199
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：A55 / A55
页数：1
相关论文
共 50 条
  • [21] Prognostic value of BNP in patients admitted with decompensated heart failure
    Rey, Helena C. V.
    Bittencourt, Marcelo I.
    Rangel, Fernando O. D.
    Rocha, Ricardo M.
    Esporcatte, Roberto
    Xavier, Sergio S.
    [J]. JOURNAL OF CARDIAC FAILURE, 2006, 12 (06) : S131 - S131
  • [22] Quality of life of hospitalized patients with heart failure, NYHA IV
    Kikira, A.
    Koutelekos, I.
    Parissopoulos, S.
    Tsami, A.
    Fouka, G.
    Polikandrioti, M.
    [J]. ARCHIVES OF HELLENIC MEDICINE, 2018, 35 (04): : 490 - 496
  • [23] PREDICTORS OF RESPONSE IN PATIENTS WITH ACUTE DECOMPENSATED HEART FAILURE REQUIRING MILRINONE
    Turner, J. L.
    Teuteberg, J. J.
    Mathier, M. A.
    Ramani, R.
    Ishizawar, D.
    Simon, M. A.
    McNamara, D.
    Lampert, B. C.
    [J]. CARDIOLOGY, 2015, 131 : 365 - 365
  • [24] Effects of Levosimendan and Dobutamine on Systolic Time Intervals in Patients with Acute Decompensated Heart Failure
    Cavusoglu, Yuksel
    Nadir, Aydin
    Mert, Kadir Ugur
    Gencer, Erkan
    Morrad, Bektas
    Mutlu, Fezan
    Ulus, Taner
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 62 (18) : C102 - C102
  • [25] Effects of levosimendan and dobutamine on systolic time intervals in patients with acute decompensated heart failure
    Cavusoglu, Y.
    Nadir, A.
    Mert, K. U.
    Gencer, E.
    Mutlu, F.
    Ulus, T.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2013, 12 : S148 - S149
  • [26] Adjustment of oral medications in class IV heart failure patients receiving intravenous milrinone therapy
    MildredLaForest, SK
    Shubert, J
    Mendoza, B
    Mather, PJ
    Burke, J
    Mancano, MA
    Bove, AA
    Eisen, HJ
    Jeevanandam, V
    Pina, IL
    [J]. CIRCULATION, 1996, 94 (08) : 136 - 136
  • [27] SYSTEMIC AND CORONARY EFFECTS OF INTRAVENOUS MILRINONE AND DOBUTAMINE IN CONGESTIVE-HEART-FAILURE
    GROSE, R
    STRAIN, J
    GREENBERG, M
    LEJEMTEL, TH
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1986, 7 (05) : 1107 - 1113
  • [28] Anxiety in heart failure patients and its association with NYHA class
    Costa, F.
    Martins, S.
    Moreira, E.
    Silva Cardoso, J.
    Fernandes, L.
    [J]. EUROPEAN PSYCHIATRY, 2021, 64 : S190 - S190
  • [29] Milrinone or dobutamine in patients with heart failure: evidence from meta-analysis
    Szarpak, Lukasz
    Szwed, Piotr
    Gasecka, Aleksandra
    Rafique, Zubaid
    Pruc, Michal
    Filipiak, Krzysztof J.
    Jaguszewski, Milosz J.
    [J]. ESC HEART FAILURE, 2022, 9 (03): : 2049 - 2050
  • [30] Myocardial injury markers in patients with ambulatory class NYHA III-IV ischemic heart failure
    Maroz-Vadalazhskaya, N.
    Russkikh, I.
    Kaljadka, M.
    Seljun, Y.
    Kurganovich, S.
    Ostrovski, Y.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2013, 12 : S61 - S61
12345